Ann: Pfizer raises scheme consideration to A$0.208 per share, page-5

I’ll wait this out and cash in on 10 years time where I suspect the technology will be mainstream and integrated in many health platforms and devices across the world. The share price will reflect this as will the dividends.

all my very own opinion and speculation. Do your own research and think about it —— 20.8 cents pffft